جست‌وجوی استاد و پژوهشگر

Gonzalo del Monte Nietoمشاهده پروفایل

پژوهشگر ارشد

• Developmental Biology
• Cardiovascular Development
• Congenital Heart Disease
• +۳ مورد دیگر

Dr Gonzalo del Monte Nieto is a Senior Research Fellow at the Australian Regenerative Medicine Institute (ARMI) and Victorian Heart Institute (VHI) at Monash University. His research focuses on understanding molecular mechanisms and developmental processes in heart development, with applications to congenital heart disease and cardiac regeneration. He holds a PhD in Molecular Biology from the Autonomous University of Madrid (2011) and has held academic positions including Con-joint Senior Lecturer at UNSW (2015–2018) and postdoctoral roles at the Victor Chang Cardiac Research Institute (2011–2018). Education : PhD in Molecular Biology, Autonomous University of Madrid (2011) Masters in Molecular Biology, Autonomous University of Madrid (2007) Bachelor of Biology, Autonomous University of Madrid (2005) Research Interests : Dr del Monte Nieto's work integrates developmental biology with clinical applications, particularly in congenital heart disease and regenerative medicine. Key areas include: Notch signaling pathways in cardiac development ECM dynamics and cardiac trabeculation Computational modeling of heart development Organ-on-chip technologies for cardiac research Grants & Projects : 2024: Company of Biologist Conference Grant (Chief Investigator) 2021: NHMRC Project Grant on Endocardial Sprouting (Chief Investigator) 2019: National Heart Foundation Grant on Cardiac Development Models (Primary Investigator) Labs & Teams : He leads a team focused on cardiac regeneration and developmental biology at ARMI. Collaborations include projects with Prof Richard Harvey’s lab and international institutions.

Tracy Hengمشاهده پروفایل

دانشیار

• Stem Cell Therapy
• Immunology
• Cell Therapy
• +۳ مورد دیگر

Associate Professor Tracy Heng is an academic at Monash University, leading research on overcoming immunological barriers in stem cell therapies. She holds a PhD from Monash University and completed postdoctoral training at Harvard Medical School. Her roles include Laboratory Head in the Department of Anatomy & Developmental Biology and Deputy Head of the Immunity Program at the Monash Biomedicine Discovery Institute. Education: PhD, Monash University (strategies to improve immune function in ageing) Postdoctoral training with Professors Harald von Boehmer, Christophe Benoist, and Diane Mathis (Harvard Medical School, Immunological Genome Project) Research Interests: Understanding immune responses to stem cell transplantation, optimizing cell therapies, and addressing immunological challenges. Key areas include mesenchymal stromal cell apoptosis, lymphoid organ roles in therapy, and macrophage biology. Recent Articles: Focus on apoptosis-driven therapeutic mechanisms, stromal cell interactions with lymph nodes, and cytokine effects on cell survival. Recent work highlights the critical role of apoptosis in therapeutic efficacy and the importance of secondary lymphoid organs in cell therapy. Awards: 2015 Young Tall Poppy Science Award 2016 Metcalf Prize for Stem Cell Research 2016 NHMRC R.D. Wright Fellowship 2011 ARC Postdoctoral (Industry) Fellowship Projects: Leading projects such as 'The mesenchymal stromal cell paradox' (2022–2025) and 'Surface coatings for directed differentiation of iPSCs to T-cells' (2023–2026). Collaborates on initiatives like the ARC Training Centre for Cell and Tissue Engineering Technologies. Labs/Teams: Leads a research group focused on immunological barriers in stem cell therapies within the Monash Biomedicine Discovery Institute.

Mark Del Borgoمشاهده پروفایل

مدرس ارشد

• Peptide materials
• Bioengineering
• Drug delivery
• +۳ مورد دیگر

Dr. Mark Del Borgo is a Senior Lecturer and Lab Head of the Macro Therapeutics Lab in the Department of Pharmacology at Monash University's Faculty of Medicine, Nursing and Health Sciences. He specializes in peptide science, particularly in pharmacological characterization of peptides and their applications in regenerative medicine, bioengineering, and drug delivery. Education: PhD in Pharmacology (University of Melbourne, 2005); BSc(Hons) in Pharmacology (University of Melbourne, 2000). Career highlights include postdoctoral roles at the University of Queensland (2005–2007) and University of Kansas (2007–2008), followed by a research fellowship at Monash University (2009–present). He pioneered β-amino acid-derived peptide self-assembly into fibrous materials, published in Angew. Chem. Int. Ed. . Research focuses on peptide materials, bioengineering, and drug delivery, with contributions to anti-fibrotic agents, hydrogel technologies, and angiotensin receptor modulation. Key projects include injectable hydrogels for diabetic organ protection and SARS-CoV-2 inhibitors targeting ACE2 receptors. His work aligns with UN Sustainable Development Goals related to health and innovation. Grants and collaborations include projects on diabetic kidney damage, anti-fibrotic peptide mimics, and cardiac fibrosis treatment. He heads a lab advancing β-peptide-based platforms for therapeutic applications and leads multidisciplinary teams in drug development and biomaterials research.

Margherita Bertuzziمشاهده پروفایل

مدرس

• Molecular Microbiology
• Fungal Pathogenesis
• Host-Pathogen Interactions
• +۳ مورد دیگر

Dr. Margherita Bertuzzi is a Lecturer in Molecular Microbiology at the University of Manchester, affiliated with the Division of Evolution, Infection and Genomics and the Manchester Fungal Infection Group (MFIG). She holds roles as Co-Director of the MSc Infection Biology program and PGT Unit Lead for Host-Pathogen Interaction lectures and Research Project II. Her research focuses on fungal infection biology, particularly the antifungal phagocytic activities of respiratory epithelia in health and disease, with emphasis on pH-mediated signaling and COPD-related dysfunctions. She leads a team employing single-cell technologies and immunological analyses to study fungal-epithelial interactions. Education: BSc (Hons) Molecular Biology, University of Padua, Italy (2002-2005) MRes Human Health Biology, University of Padua, Italy (2005-2007) PhD Molecular Mycology, Imperial College London, UK (2007-2011) Research Interests: Her work explores epithelial encounters with respiratory pathogens, immune response modulation, and translational applications. Key areas include Aspergillus fumigatus pathogenesis, COPD exacerbations, and host-microbe interactions using cutting-edge imaging and single-cell techniques. Awards: MRC Discovery award (2017) MRC New Investigator Research grant (2021) Teaching & Mentoring: She delivers lectures on molecular mycology, mentors PGT students, and oversees research projects. Recent supervisees include PhD candidates (e.g., Patrick Dancer) and MSc/MRes students (e.g., Anna Möslinger, Caitlin Sergienko). Labs & Collaborations: Collaborations with Manchester University NHS Foundation Trust and the National Aspergillosis Centre support clinical translation. Her lab integrates interdisciplinary approaches to address fungal infection challenges aligned with UN SDG 3 (Good Health).

Alexander Hoffmannمشاهده پروفایل

استاد

• NFκB signaling
• IRF signaling
• Innate immunity
• +۶ مورد دیگر

Professor Alexander Hoffmann at the Department of Microbiology, Immunology & Molecular Genetics at University of California Los Angeles is a leading systems immunologist focusing on the dynamic regulation of immune signaling networks. His work integrates experimental approaches (biochemistry, molecular biology, live-cell imaging, next-gen sequencing) with computational modeling to decode how immune cells like macrophages and B-cells make stimulus-specific decisions. Education: BA in Physics from Cambridge University (1988), PhD in Biochemistry of TFIID from Rockefeller University (1994), Postdoc in HIV latency control at MIT (1998), and Postdoc in NFκB systems immunology at Caltech (2003). His research uncovers how NFκB and IRF signaling systems govern immune cell responses through temporal dynamics and network architecture. Current projects explore macrophage stimulus specificity , B-cell antibody response regulation , and hematopoietic aging mechanisms , supported by NIH grants as Principal Investigator. Recent publications focus on single-cell signaling fidelity , dynamic gene regulatory logic , and computational approaches to immune modeling . His 15 most recent articles (2024-2025) reveal a strong emphasis on signaling dynamics , immune training , and multi-scale modeling . Scientific Awards: UCLA Undergraduate Research Mentor Award (2023) Thomas M Asher Endowed Chair in Microbiology (2014–present) Hellman Fellow (2007–2008) Ellison Medical Foundation Scholar in Aging Research (2005–2009) Multiple graduate and postdoctoral fellowships He mentors through the Bruins in Genomics program and leads interdisciplinary research at the QCBio Institute , bridging biochemistry , mathematical modeling , and computational biology to understand immune decision-making.

• Iron metabolism
• Anemia
• Iron overload
• +۳ مورد دیگر

Elizabeta Nemeth is a Professor of Medicine at the David Geffen School of Medicine, UCLA, and Director of the UCLA Center for Iron Disorders. She specializes in iron metabolism research, focusing on hepcidin and ferroportin roles in health and disease. Affiliations: UCLA Clinical and Translational Science Institute, UCLA Digestive Diseases Research Center Education: PhD in Cell, Molecular & Neurosciences (University of Hawaii, 1998); BS in Molecular Biology (University of Belgrade, 1993) Her research explores iron regulation in anemia, pregnancy, and disorders like β-thalassemia. Key contributions include discovering erythroferrone's role in erythropoiesis-driven iron regulation and developing hepcidin-targeted therapies. Research Interests: Hepcidin biology, iron overload mechanisms, pregnancy iron dynamics, anemia of inflammation, and translational therapeutics. Her work bridges basic science and clinical applications, including diagnostics and drug development. Awards: William Dameshek Prize (2021), International BioIron Society Presidential Award (2019), Grace Goldsmith Award (2007). Her research has led to three biotech startups focused on iron disorder treatments. Grants: NIH-funded projects on iron physiology in pregnancy, erythroferrone's role, and iron's impact on atherosclerosis Labs/Teams: Directs UCLA Center for Iron Disorders, collaborates with NIH-funded research networks

Liz Johnsonمشاهده پروفایل

استادیار

• Sphingolipid Metabolism
• Host-Microbe Interactions
• Infant Nutrition
• +۴ مورد دیگر

Liz Johnson is an Assistant Professor in the Division of Nutritional Sciences at Cornell University, part of the College of Human Ecology. Her research focuses on sphingolipid-dependent host-microbe interactions, infant nutrition, and microbiome dynamics. She employs advanced techniques such as high-throughput sequencing and lipidomics to study how microbial sphingolipids influence host metabolism, insulin signaling, and disease prevention. Her work also explores the role of sphingolipids in human milk and their impact on infant gut microbiome development. Research Interests: Host-microbe signaling pathways Sphingolipid metabolism in health and disease Infant nutritional programming Microbiome-liver axis interactions Recent studies highlight her lab’s exploration of microbiome-driven mechanisms in metabolic disorders and skin health. Collaborative projects with institutions studying lipid metabolism and aquaculture nutrition further extend her research portfolio. Awards: No scientific awards were explicitly mentioned in the provided texts. Advising & Grants: The Johnson Lab conducts research funded by grants focusing on microbiome and metabolic health. Specific grant details are not listed here, but the lab actively collaborates on projects analyzing diet-microbiome interactions and lipid biomarkers. Labs/Teams: The Johnson Lab at Cornell University is dedicated to advancing understanding of host-microbe interactions through lipidomics and microbiome analysis. The lab collaborates with groups in nutritional sciences and microbiology to address translational questions in human health.

Kate Staceyمشاهده پروفایل

استاد

• Innate Immunity
• Inflammasome Signaling
• Autoimmunity Mechanisms
• +۳ مورد دیگر

Professor Kate Stacey holds dual roles as Director of Research and Professor within the School of Chemistry and Molecular Biosciences at The University of Queensland, Faculty of Science. Her research focuses on innate immune cell activation by pathogen products, particularly mechanisms of DNA recognition and inflammasome signaling. She completed her PhD at UQ on macrophage transcriptional regulation and held a CJ Martin Fellowship at the University of Cambridge before returning to UQ in 1996. She was awarded an ARC Future Fellowship in 2009. Education: Bachelor (Honours) of Science (Advanced), The University of Queensland Doctor of Philosophy, The University of Queensland Her research interests include: - Recognition of foreign DNA via TLR9, AIM2, and cGAS pathways - Inflammasome-induced cell death mechanisms (caspase-1/pyroptosis and caspase-8 apoptosis) - Autoimmunity in lupus through dysregulated innate immune responses - Evolutionary conservation of DNA defense mechanisms across species Recent work highlights structural biology insights into TLR signaling complexes and inflammasome activation pathways, with implications for viral infections like dengue and SARS-CoV-2. Key findings include dual death pathways activated by inflammasomes and novel therapeutic approaches targeting TLR4 signaling. Awards: ARC Future Fellowship (2009), NHMRC Research Fellowship (2014–2019), multiple NHMRC Project Grants. Supervision: Active advisor for PhD students researching TLR signaling, dengue pathogenesis, and evolutionary immune mechanisms. Has supervised over 20 completed theses since 2003.

Ivan Marazziمشاهده پروفایل

دانشیار

• Epigenetics
• Transcriptional Regulation
• NF-kappaB Signaling
• +۲ مورد دیگر

Ivan Marazzi is Associate Professor of Biological Chemistry at UC Irvine School of Medicine, leading the Center for Epigenetics & Metabolism. Research explores transcriptional regulation dynamics, NF-kappaB signaling, and chromatin organization in inflammation and host-virus interactions. Recent investigations focus on circadian control of immunity, DNA damage responses, and therapeutic targeting of inflammatory pathways. The lab employs molecular biology and genomics approaches to study transcriptional mechanisms in viral infections, cancer, and immune disorders.

• Neuroscience
• Immunology
• Chronic Neuropathic Pain
• +۴ مورد دیگر

Associate Professor Paul Austin is affiliated with the School of Medical Sciences at the University of Sydney's Faculty of Medicine and Health. His research focuses on neuro-immune mechanisms underlying chronic neuropathic pain, particularly exploring inflammatory mediators and their roles in affective disabilities and motor deficits. He teaches neuroanatomy and neuroscience to medical and science students, specializing in basal ganglia anatomy and nociceptive pathways. Current research projects investigate neuroimmune interactions in chronic pain and neurodegeneration, using rodent models to study behavioral changes and immune activation in human conditions like Complex Regional Pain Syndrome (CRPS). His work integrates neuroanatomical, immunohistochemical, and imaging techniques. Grants: 2022: Machine learning-based disease models for spinal cord imaging 2021: CRPS immune-autonomic dysfunction analysis 2019: Photobiomodulation in Sanfilippo syndrome Students: Supervising Fred COLLIN, Dolores HUANG, and Jackson KARRASCH on neuroimmune mechanisms, CRPS imaging, and high-parameter cytometry. Labs: Focuses on neuroinflammation, pain biomarkers, and translational neuroimmunology.

Veronica Tomمشاهده پروفایل

استاد

• Spinal Cord Injury
• Axon Regeneration
• Neurobiology
• +۳ مورد دیگر

Veronica Tom, PhD, is a Professor in the Department of Neurobiology & Anatomy at Temple University’s College of Medicine. Her research focuses on spinal cord injury (SCI), particularly axon regeneration and mitigating autonomic dysfunction post-injury. She holds a BS in Neural Science from New York University and a PhD in Neurosciences from Case Western Reserve University. Her work involves advanced techniques like cell transplantation, gene manipulation, and cardiovascular function assessment. Funded by the NIH and Craig H. Neilsen Foundation, her lab explores strategies to enhance functional recovery after SCI. Notable achievements include a 2017 CURE Grant Award. Collaborations span surgical, pharmacological, and biomaterial approaches to address SCI-related deficits. Research interests emphasize axon regeneration mechanisms, autonomic dysreflexia, and immune dysfunction post-injury. Techniques employed include survival surgery, gene editing, and behavioral assessments of motor/sensory function. The lab’s website ( tom-lab.org ) provides further details on ongoing projects and publications. Key awards include the 2017 Commonwealth of Pennsylvania CURE Grant. Her work highlights interdisciplinary approaches, combining neurobiology, immunology, and engineering to address SCI challenges. Current research trends focus on enhancing axonal regeneration via microtubule dynamics and mitigating secondary complications like cardiovascular and immune dysfunction.

• Reproductive Biology
• Oocyte Maturation
• Proteolysis Mechanisms
• +۲ مورد دیگر

Filiz Tepekoy serves as Lecturer in Biomedical Science with specialization in Histology at the College of Science and Engineering. Her research program centers on cellular mechanisms in reproductive biology, particularly proteolytic processes during oocyte maturation. Recent publications investigate signaling pathways in gamete development and stem cell applications. Research domains include: Molecular regulation of oocyte maturation and fertilization Wnt signaling pathways in reproductive tissues Stem cell differentiation and therapeutic applications Histological analysis of reproductive systems Her publication record demonstrates consistent focus on fundamental reproductive mechanisms, with recent work examining kinase regulation in oocyte development (2023) and PIP2 signaling effects (2020). Technical expertise spans immunohistochemistry, cell culture, molecular biology techniques, and histological analysis across multiple model systems.

• Behavioral Neuroscience
• Pharmacology
• Pain Mechanisms
• +۵ مورد دیگر

Ram Kandasamy, PhD, is an Associate Professor in the Department of Psychology at California State University, East Bay (CSUEB), where he has served since 2019 and earned early tenure in 2024. He teaches courses in Physiological Psychology, Experimental Psychology, and Drugs and Behavior, while mentoring undergraduate research trainees. His NIH-funded research focuses on developing non-opioid pain treatments, particularly through multitarget enzyme inhibitors for orofacial and inflammatory pain. He actively involves undergraduates in all research stages, many of whom have published and presented at national conferences. Dr. Kandasamy holds a B.S. in Neuroscience and Psychology (magna cum laude, Washington State University) and a Ph.D. in Neuroscience (Washington State University, Vancouver). His postdoctoral training at the University of Michigan Medical School explored opioid analgesics and their abuse potential. He serves as Principal Investigator for the Beckman Scholars Program and previously led the Center for Student Research as Interim Director. His research integrates behavioral neuroscience, pharmacology, and translational models, with a focus on cannabinoid analgesia, opioid receptor modulation, and enzyme inhibitor development. Key contributions include pioneering wheel-running assays for pain assessment and advancing understanding of pain mechanisms in chronic conditions. Grants/Leadership: NIH-funded projects, Beckman Scholars Program PI, ASPET executive roles, CSUBIOTECH Faculty Consensus Group Labs/Teams: Active lab developing pain therapies, undergraduate research mentorship focus Current research emphasizes dual inhibitors targeting FAAH and sEH enzymes, as well as cannabinoid-based pain therapies. His work bridges basic science and clinical applications, fostering student development through hands-on research opportunities.

Roger Rosenbergمشاهده پروفایل

استاد

• Alzheimer's Disease
• Neurodegenerative Diseases
• DNA Vaccines
• +۳ مورد دیگر

Roger Rosenberg, M.D., is a Professor of Neurology and Neurotherapeutics and Physiology at the University of Texas Southwestern Medical Center, where he has been affiliated since 1973. He served as Chair of the Department of Neurology from 1973 to 1991 and is the founding Director of the NIH-funded Alzheimer’s Disease Center, continuously supported since 1988. His research focuses on Alzheimer’s disease and neurodegenerative disorders, including the development of a DNA Aβ42 vaccine and studies of amyloid precursor protein processing. Rosenberg also contributed to understanding genetic neurological diseases like Machado-Joseph disease, identifying CAG triplet repeats as causative mutations. He holds the Abe (Brunky), Morris and William Zale Distinguished Chair and a US Patent for amyloid beta gene vaccines (2009). His work combines molecular genetics, immunology, and clinical research. Key achievements include demonstrating platelet Aβ42 as a biomarker for Alzheimer’s and showing DNA vaccination’s potential in reducing amyloid and tau pathology in preclinical models. Rosenberg’s research spans translational medicine, from bench-to-clinic, with a focus on therapeutic development. Awards include sustained NIH funding for his Alzheimer’s Center and his patented vaccine. He authored textbooks such as Rosenberg's Molecular and Genetic Basis of Neurologic and Psychiatric Disease (6th ed., 2020). His lab investigates memory mechanisms, proposing a genetic model involving epigenomic signaling in synapses.

Venuprasad Poojaryمشاهده پروفایل

دانشیار

• Immunology
• Gastrointestinal Disorders
• Inflammation Regulation
• +۳ مورد دیگر

Venuprasad Poojary, Ph.D., is an Associate Professor in the Departments of Internal Medicine and Immunology at UT Southwestern Medical Center and a member of the Division of Digestive and Liver Diseases. He joined the faculty in 2019. His research focuses on regulatory mechanisms of immune cells in gastrointestinal inflammation and cancer, with a goal to identify therapeutic targets for chronic inflammatory diseases. Education: B.Sc. in Biochemistry (Mangalore University), M.Sc. in Bioscience (Mangalore University), Ph.D. in Immunology (National Center for Cell Science, Kolkata). Postdoctoral training at La Jolla Institute for Allergy and Immunology (San Diego). Research interests include Th17 cell regulation, RORγt signaling, mitochondrial dysfunction in inflammation, and immunotherapeutic approaches for intestinal disorders. His lab investigates mechanisms linking inflammation to cancer and autoimmune conditions, with recent work on protein modifications and mitochondrial pathways. Publications span topics like colonic inflammation, T-cell exhaustion, and Wnt/β-catenin inhibition, emphasizing translational research. He is affiliated with professional organizations including the American Association of Immunologists and American Association for Cancer Research. Led by Dr. Poojary, the Poojary Research Lab collaborates on projects addressing immune checkpoints and therapeutic development. No specific grants or advisees are listed, but the lab actively engages in collaborative research initiatives.